Blood sugar and insulin
Curcuminand HOMA-IR
Both sources here measured lower HOMA-IR.
How sure anyone can be
Low certainty, level 2 of 4Further research is likely to change this.
The most certain of the two findings here; each record carries its own.
The numbers reported
One source’s range, drawn against its own line of no difference and scaled to its own numbers.
-1.6-1.01-0.42
This range stays on one side of the no-difference line.
Two sources, newest first
What we read is the published abstract, not the full paper, so a blank below may still be printed in the paper itself. A fixed rule worked this out from the source’s own fields. Nobody checked this rating by hand.
Systematic review, 2024
Very low certainty, level 1 of 4Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.
Complement Ther Med. 2024;80:103025. doi:10.1016/j.ctim.2024.103025. PMID:38232906.
- Number reported
- -0.52
- Which way it went
- Lower
- Likely range
- -0.84 to -0.2
- Source’s own words
- weighted mean difference in HOMA-IR vs control
- Who was studied
- Adult with NAFLD
- Compared with
- control
- Amount taken
- 50 to 3,000 mg/d
- For how long
- Not in the abstract
- Disagreement between studies
- I2 = 82.8%
- Kind of record
- Journal article
How this rating was reachedstarts at High, 3 steps down: risk of bias, imprecision and inconsistency
- Starts at High
- Risk of bias brought it down to Moderatethe abstract reports no risk-of-bias or quality appraisal, so study limitations cannot be ruled outNot in the abstract
- Imprecision brought it down to Lowthe abstract does not state how many participants were pooledNot in the abstract
- Inconsistency brought it down to Very lowheterogeneity across pooled studies is high (I² = 82.8%)Reported in the abstract
- Ends at Very low3 steps down.
- Checked, nothing to step it down for
- indirectness
Imprecision stops at the first check that applies; others may apply too.
Source saved; quote checked byte-for-byte against it by software; no signature.
Systematic review, 2022
Low certainty, level 2 of 4Turmeric and curcuminiods ameliorate disorders of glycometabolism among subjects with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials.
Pharmacol Res. 2022;177:106121. doi:10.1016/j.phrs.2022.106121. PMID:35143971.
- Number reported
- -1.01
- Which way it went
- Lower
- Likely range
- -1.6 to -0.42
- Source’s own words
- HOMA-IR index units, weighted mean difference vs control
- Who was studied
- Adult with metabolic disease
- Compared with
- control
- Amount taken
- Not in the abstract
- For how long
- Not in the abstract
- Disagreement between studies
- abstract states significant heterogeneity; no I2 printed for HOMA-IR
- Kind of record
- Journal article
How this rating was reachedstarts at High, 2 steps down: risk of bias and imprecision
- Starts at High
- Risk of bias brought it down to Moderatethe abstract reports no risk-of-bias or quality appraisal, so study limitations cannot be ruled outNot in the abstract
- Imprecision brought it down to Lowthe abstract does not state how many participants were pooledNot in the abstract
- Ends at Low2 steps down.
- Checked, nothing to step it down for
- indirectness
- Inconsistency
- No disagreement reported, and no count of studies behind it
Imprecision stops at the first check that applies; others may apply too.
AI-reviewed & signed — an AI agent re-read this finding against the saved source and checked that the quote, the numbers, the units and the direction match it. No person read it. The owner authorised the agent to sign the batch with the owner's key, and every build rechecks that signature against these exact bytes.
What is still missing from these readings
- Two do not say how many people took part.
- Amount taken — One of Two readings: Not in the abstract.
- For how long — Not in the abstract.
Something nobody wrote down is never a zero and never a guess.
Still to read for Curcumin
Four of the 22 things on our list for Curcumin have no reading here yet:
- Fasting insulin
- Type 2 Diabetes Incidence
- Ulcerative Colitis Disease Activity Index
- WOMAC Physical Function Subscale
Still to read means nobody here has got to it, not that it was tried and did nothing or that no research exists. A pairing on no list is not a gap: we never set out to read it.
Read next
Curcumin
17 other questions read for it
Blood sugar and insulin
52 questions read under it
HOMA-IR
11 other ingredients read against it
First six, alphabetical, and by nothing else. The rest are on Blood sugar and insulin.
This is a library, not advice. No recommendation, no dose, no diagnosis, no ranking. We never ask about your symptoms, and nothing here is tailored to you.